Business
ProAxsis: Sales Update
ProAxsis: Sales Update.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 0220X NetScientific PLC 21 November 2017 \n\nNetScientific plc\n(\"NetScientific\" or the \"Company\" or the \"Group\")\n \nProAxsis Announces Sales Acceleration of its CE Marked Active Neutrophil Elastase Immunoassay\n \nLondon, UK - 21 November 2017 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes the announcement by its portfolio company, ProAxsis, which today provides an update on sales of its ProteaseTag® Active Neutrophil Elastase Immunoassay (NEIA). ProAxsis forecasts direct sales of the NEIA to increase by a factor of three in the H2 2017 period compared to H1 2017 and expect total revenue to surpass £1m in 2018. \nCommenting on the news, Francois Martelet, Chief Executive Officer of NetScientific and Chairman of ProAxsis, said: \"We are pleased to see signs of rapid market adoption of the CE marked NEIA test which uses ProAxsis' market leading ProteaseTag® technology. We are especially encouraged to see the acceleration of sales through a combination of repeat orders and new customers from leading research institutions across Europe and the US. We expect 2018 to be a pivotal year for ProAxsis with further planned product launches and potential industry partnerships as value inflection points.\"\n \nNetScientific holds a 57% stake on a fully diluted basis in ProAxsis.\n \nThe full text of the announcement from ProAxsis can be found below.\n \n \n# # #\n \nFor more information, please contact:\n \n\n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott / Jessica Hodgson /\n Chris Welsh / Laura Thornton \n \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nStifel Nicolaus Europe Limited (NOMAD and Broker)\nJonathan Senior / David Arch / Ben Maddison\n\n\n Tel: +44 (0) 20 7710 7600\n\n\n\n\n \nProAxsis provides update on commercialisation progress\nDate: November 21, 2017\nHaving reached the first anniversary following relocation to its new purpose-built laboratory on the Catalyst Inc. site in the Titanic Quarter of Belfast, ProAxsis is pleased to provide an update o...